Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease

American Journal of Gastroenterology

Volumn 105, Issue 9, 2010, Pages 2093-2102

  Patton, Heather M ^a   Yates, Katherine ^b   Unalp Arida, Aynur ^b   Behling, Cynthia A ^c   Huang, Terry T K ^d   Rosenthal, Philip ^e   Sanyal, Arun J ^f   Schwimmer, Jeffrey B ^a   Lavine, Joel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Pacific Rim Pathology Medical Corporation   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; DISEASE ACTIVITY; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; COMPLICATION; FACTUAL DATABASE; INSULIN RESISTANCE; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; RISK; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; DATABASES, FACTUAL; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; ODDS RATIO; SEVERITY OF ILLNESS INDEX;

EID: 77956339546     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.152     Document Type: Article

References (49)

1. Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 2007; 133: 1814-1820
2. Schwimmer JB, Deutsch R, Kahen T et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553
4. Grundy SM, Brewer HB Jr, Cleeman JI et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438
5. Marchesini G, Marzocchi R, Agostini F et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16: 421-427
6. Kang H, Greenson JK, Omo JT et al. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 2006; 101: 2247-2253
7. Ryan MC, Wilson AM, Slavin J et al. Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care 2005; 28: 1222-1224
8. Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923
9. Park HS, Han JH, Choi KM et al. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005; 82: 1046-1051
10. Schwimmer JB, Pardee PE, Lavine JE et al. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008; 118: 277-283
11. Manco M, Marcellini M, Devito R et al. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32: 381-387
12. Lavine JE, Schwimmer JB. Pediatric initiatives within the Nonalcoholic Steatohepatitis-Clinical Research Network (NASH CNR). J Pediatr Gastroenterol Nutr 2003; 37: 220-221
13. Patton HM, Lavine JE, Van Natta ML et al. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 2008; 135: 1961-1971 e2
14. Lavine JE, Schwimmer JB, Molleston JP et al. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemporary Clinical Trials 2010; 31: 62-70
15. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11; 2002: 1-190
16. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
17. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410
18. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321
19. Kleiner DE, Behling CB, Brunt EM et al. Comparison of adult and pediatric NAFLD-confirmation of a second pattern of progressive fatty liver disease in children. Hepatology 2006; 44: 259A-60A
20. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res 2005; 33: 68-71
21. Schwimmer JB, Behling C, Newbury R et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 42: 641-649
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-4421
23. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555-576
24. Hickman TB, Briefel RR, Carroll MD et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Th ird National Health and Nutrition Examination Survey. Prev Med 1998; 27: 879-890
25. Schulpis K, Karikas GA. Serum cholesterol and triglyceride distribution in 7767 school-aged Greek children. Pediatrics 1998; 101: 861-864
26. Jolliffe CJ, Janssen I. Distribution of lipoproteins by age and gender in adolescents. Circulation 2006; 114: 1056-1062
27. Yip PM, Chan MK, Nelken J et al. Pediatric reference intervals for lipids and apolipoproteins on the VITROS 5,1 FS Chemistry System. Clin Biochem 2006; 39: 978-983
28. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl 1): S55-60
29. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062
30. Agresti A. Categorical Data Analysis. John Wiley & Sons, Inc.: New York, 1990
31. McCullagh P. Regression models for ordinal data (with discussion). Journal of the Royal Statistical Society, B 1980; 42: 109-142
32. Brant R. Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics 1990; 46: 1171-1178
33. Hosmer D, Lemeshow S. Applied Logistic Regression. Second edn. John Wiley & Sons, Inc.: New York, 2000
34. Patton HM, Unalp A, Yates K et al. Metabolic syndrome among children with variable features of nonalcoholic fatty liver disease. Hepatology 2007; 46: 730A
35. Pan Y, Pratt CA. Metabolic syndrome and its association with diet and physical activity in US adolescents. J Am Diet Assoc 2008; 108: 276-286; discussion 286
36. Ford ES, Li C, Zhao G et al. Prevalence of the metabolic syndrome among US adolescents using the definition from the International Diabetes Federation. Diabetes Care 2008; 31: 587-589
37. Messiah SE, Arheart KL, Luke B et al. Relationship between body mass index and metabolic syndrome risk factors among US 8-to 14-year-olds, 1999-2002. J Pediatr 2008; 153: 215-221
38. Cook S, Auinger P, Li C et al. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. J Pediatr 2008; 152: 165-170
39. Kranz S, Mahood LJ, WagstaffDA. Diagnostic criteria patterns of US children with Metabolic Syndrome: NHANES 1999-2002. Nutr J 2007; 6: 38
40. Day CP, James OF. Steatohepatitis: a tale of two " hits "? Gastroenterology 1998; 114: 842-845
41. Lewis GF, Carpentier A, Adeli K et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-229
42. Azzout-Marniche D, Becard D, Guichard C et al. Insulin Effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem J 2000; 350 (Part 2): 389-393
43. Namikawa C, Shu-Ping Z, Vyselaar JR et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 2004; 40: 781-786
44. Letteron P, Sutton A, Mansouri A et al. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 2003; 38: 133-140
45. Charlton M, Sreekumar R, Rasmussen D et al. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904
46. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404
47. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165
48. Raitakari OT, Juonala M, Kahonen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Jama 2003; 290: 2277-2283
49. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007; 120: 340-345